- Home
- JMM vs ZYXI Comparison
JMM vs ZYXI Comparison
Compare JMM & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMM
- ZYXI
- Stock Information
- Founded
- JMM 1988
- ZYXI 1996
- Country
- JMM United States
- ZYXI United States
- Employees
- JMM N/A
- ZYXI N/A
- Industry
- JMM Trusts Except Educational Religious and Charitable
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- JMM Finance
- ZYXI Health Care
- Exchange
- JMM Nasdaq
- ZYXI Nasdaq
- Market Cap
- JMM 58.5M
- ZYXI 66.5M
- IPO Year
- JMM N/A
- ZYXI N/A
- Fundamental
- Price
- JMM $6.18
- ZYXI $2.34
- Analyst Decision
- JMM
- ZYXI Buy
- Analyst Count
- JMM 0
- ZYXI 3
- Target Price
- JMM N/A
- ZYXI $6.00
- AVG Volume (30 Days)
- JMM 16.1K
- ZYXI 170.3K
- Earning Date
- JMM 01-01-0001
- ZYXI 07-24-2025
- Dividend Yield
- JMM 5.44%
- ZYXI N/A
- EPS Growth
- JMM N/A
- ZYXI N/A
- EPS
- JMM N/A
- ZYXI N/A
- Revenue
- JMM N/A
- ZYXI $172,401,000.00
- Revenue This Year
- JMM N/A
- ZYXI N/A
- Revenue Next Year
- JMM N/A
- ZYXI $19.55
- P/E Ratio
- JMM N/A
- ZYXI N/A
- Revenue Growth
- JMM N/A
- ZYXI N/A
- 52 Week Low
- JMM $5.29
- ZYXI $1.66
- 52 Week High
- JMM $6.10
- ZYXI $10.62
- Technical
- Relative Strength Index (RSI)
- JMM 55.51
- ZYXI 48.62
- Support Level
- JMM $6.05
- ZYXI $2.21
- Resistance Level
- JMM $6.21
- ZYXI $2.66
- Average True Range (ATR)
- JMM 0.12
- ZYXI 0.19
- MACD
- JMM 0.00
- ZYXI 0.05
- Stochastic Oscillator
- JMM 63.33
- ZYXI 47.54
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.